ProShare Advisors’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,836
| Closed | -$38.2K | – | 2112 |
|
|
2025
Q1 | $38.2K | Sell |
11,836
-4,533
| -28% | -$14.6K | ﹤0.01% | 1981 |
|
|
2024
Q4 | $91.2K | Buy |
16,369
+3,783
| +30% | +$21.1K | ﹤0.01% | 2089 |
|
|
2024
Q3 | $136K | Buy |
+12,586
| New | +$136K | ﹤0.01% | 1830 |
|
|
2024
Q2 | – | Sell |
-10,788
| Closed | -$344K | – | 1901 |
|
|
2024
Q1 | $344K | Buy |
+10,788
| New | +$344K | ﹤0.01% | 1336 |
|
|
2022
Q1 | – | Sell |
-10,626
| Closed | -$233K | – | 2230 |
|
|
2021
Q4 | $233K | Buy |
+10,626
| New | +$233K | ﹤0.01% | 1935 |
|